Hyperfine (HYPR) Interest & Investment Income (2021 - 2026)
Hyperfine's (HYPR) quarterly Interest & Investment Income came in at $254000.0 in Q1 2026, down 19.87% YoY from $317000.0 in Q1 2025, and down 9.29% on a QoQ basis from $280000.0 in Q4 2025.
Hyperfine (HYPR) Interest & Investment Income (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Interest & Investment Income data on file, last reported at $254000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 19.87% year-over-year to $254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $960000.0 (down 52.31% YoY) and the FY2025 annual result came in at $1.0 million, down 58.95% from the prior year.
- Interest & Investment Income eased to $254000.0 in Q1 2026, from $280000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.0 million in Q2 2023 to a low of $1000.0 in Q1 2022.
- A 5-year average of $492470.6 and a median of $436000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 80.0% — and 2023, when it surged 86800.0%.
- Tracing HYPR's Interest & Investment Income over 5 years: stood at $558000.0 in 2022, then surged by 65.23% to $922000.0 in 2023, then sank by 52.71% to $436000.0 in 2024, then sank by 35.78% to $280000.0 in 2025, then declined by 9.29% to $254000.0 in 2026.
- The last three Interest & Investment Income figures came in at $254000.0 (Q1 2026), $280000.0 (Q4 2025), and $187000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | - |
| 10 | Hyperfine | 90.75 Mn | 45.98 Mn | 1.98 Mn | 272,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 272,000.00 |
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 585,000.00 |
| Jun 30, 2024 | 675,000.00 |
| Mar 31, 2024 | 796,000.00 |
| Dec 31, 2023 | 922,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 869,000.00 |
| Dec 31, 2022 | 558,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 3,000.00 |